February 01, 2026 — RNews

#motor function — Sunday, February 01, 2026 (1 items)

hot top new

← prev day next day →

0

Intrathecal onasemnogene abeparvovec in treatment-naive patients with spinal muscular atrophy: a phase 3, randomized controlled trial. (nature.com)

Proud CM … Finkel RS Nature Medicine 2026-02-01

#clinical trial #gene therapy #spinal muscular atrophy #motor function